Skip to main content
Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.12
+0.73 (5.89%)
May 12, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Monoclonal Antibody
302.00K
Log In
Log In
Log In
Log In
Upgrade
Monoclonal Antibody Growth
-3.82%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
302.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-3.82%
Log In
Log In
Log In
Log In
Upgrade